Clin2
NCT04499898Possibly a fitRecruiting

Carvedilol vs banding to prevent first bleeding from esophageal veins

Esophageal Varices

Treatments studied

Part of Digestive system clinical trials.

This trial compares two ways to prevent bleeding from enlarged veins in the food pipe (esophageal varices) in people with cirrhosis. It tests whether carvedilol (a blood-pressure/heart medicine) works as well as an endoscopic procedure that places small bands to reduce bleeding risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
306 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You’re older than 18 years
  • You have cirrhosis plus high blood pressure
  • A recent scope found medium to large esophageal varices
  • You have NOT had any variceal bleeding before, and you haven’t had prior prevention treatment for varices
  • You are NOT currently taking medicines that change portal pressure, like beta blockers or nitrates
  • You can’t have certain major exclusions like carvedilol allergy, pregnancy, severe heart/lung disease, severe diabetes or kidney problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06881082Recruiting
Comparing two banding methods for esophageal varices

This trial compares two different ways of using rubber bands to treat swollen veins in the food pipe (varices) caused by cirrhosis. It aims to find which method is better at preventing first-time bleeding.

Tanta, Gharbyea
NCT06594783Recruiting· Phase 4
Preventing varices bleeding with carvedilol and banding

This trial tests whether adding endoscopic banding helps prevent bleeding from enlarged varices in people with cirrhosis who still have high-risk varices despite taking carvedilol.

Taipei
NCT06594744Recruiting· Phase 4
Preventing first bleeding from varices in liver cancer patients

This trial compares two treatments (banding or a medication called carvedilol) to prevent the first episode of bleeding from enlarged veins in the esophagus in people with liver cancer. The goal is to find which approach is safer and more effective.

Taipei
NCT07587671Not yet recruiting
Comparing two treatments to prevent variceal bleeding

This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.

Chengdu
NCT06970509Recruiting
Improving treatment for stomach bleeding from liver disease

This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.

Guangzhou, Guangdong
NCT01212250Recruiting
Carvedilol to prevent esophagus bleeding in cirrhosis

This trial tests whether carvedilol can prevent the first development of swollen veins (varices) in the esophagus in people with cirrhosis who do not have them yet. It may help lower the risk of future bleeding from those veins.

New Delhi, National Capital Territory of Delhi

Hear when a new Esophageal Varices trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.